Novosibirsk Research Institute of Circulation Pathology   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Novosibirsk Russian Federation

Organization Overview

First Clinical Trial
2012
NCT01675453
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Academician EN Meshalkin Novosibirsk Research Institute of Circulation Pathology | Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health care of Russian Federation | Novosibirsk Research Institute of Pathology of Circulation